首页 | 本学科首页   官方微博 | 高级检索  
检索        

加味益气通玄方对大鼠脑缺血再灌注损伤的抑制作用
引用本文:彭艳,白雪,冯文战,刘祎,郭佳,高立.加味益气通玄方对大鼠脑缺血再灌注损伤的抑制作用[J].中成药,2021(1):61-66.
作者姓名:彭艳  白雪  冯文战  刘祎  郭佳  高立
作者单位:;1.西南医科大学附属中医医院全科医学科;2.西南医科大学附属中医医院心脑病科
基金项目:西南医科大学附属中医医院自然科学青年苗圃项目(2018XYLH-031)。
摘    要:目的探究加味益气通玄方对大鼠脑缺血再灌注损伤的抑制作用,为临床用药提供科学依据。方法72只大鼠随机分为6组,即假手术组、模型组、阿司匹林组、加味益气通玄方(27.68、13.84、6.92 g/kg)组,每组12只。除假手术组外,其余各组大鼠通过中动脉栓塞法(MCAO)缺血2 h后再灌注,再灌注24 h后分别给予27.68、13.84、6.92 g/kg加味益气通玄方或60 mg/kg阿司匹林治疗,1次/d,持续14 d。修正版神经功能缺损评分(mNSS)、氯化三苯基四氮唑(TTC)染色、苏木精-伊红(HE)染色、原位末端转移酶标记(TUNEL)评估加味益气通玄方对大鼠CRI的保护作用。蛋白免疫印迹实验检测PI3K/Akt-eNOS信号通路相关蛋白,以及凋亡相关蛋白Bcl-2、Bax、cleaved-Caspase3的表达。结果加味益气通玄方能明显降低大鼠的神经行为学评分,减少梗塞率,减轻脑组织病理学损伤,降低脑组织细胞凋亡;增加PI3K/Akt-eNOS信号通路相关蛋白p-Akt、p-NOS的表达,提高抗凋亡蛋白Bcl-2的表达,降低促凋亡蛋白Bax、cleaved-Caspase3的表达以及Bax/Bcl-2比值。结论加味益气通玄方可以改善大鼠脑缺血再灌注损伤,其作用机制可能与激活PI3K/Akt-eNOS通路有关。

关 键 词:加味益气通玄方  脑缺血再灌注损伤  PI3K/Akt-eNOS信号通路  凋亡

Effect of Supplemented Yiqi Tongxuan Formula on inhibiting cerebral ischemia reperfusion injury in rats
PENG Yan,BAI Xue,FENG Wen-zhan,LIU Yi,GUO Jia,GAO Li.Effect of Supplemented Yiqi Tongxuan Formula on inhibiting cerebral ischemia reperfusion injury in rats[J].Chinese Traditional Patent Medicine,2021(1):61-66.
Authors:PENG Yan  BAI Xue  FENG Wen-zhan  LIU Yi  GUO Jia  GAO Li
Institution:(Department of General Medicine,The Hospital of Chinese Medicine Affiliated to Southwest Medical University,Luzhou 646000,China;Department of Cardioencephalology,The Hospital of Chinese Medicine Affiliated to Southwest Medical University,Luzhou 646000,China)
Abstract:AIM To investigate the mechanism of supplemented Yiqi Tongxuan Formula on cerebral ischemia reperfusion injury in rats to clarify the scientific basis for its clinical medication.METHODS Seventy-two rats were randomly divided into 6 groups,namely the sham group,the model group,aspirin group,and groups of supplemented Yiqi Tongxuan Formula(27.68 g/kg,13.84 g/kg,6.92 g/kg),with 12 rats in each group.Except for the sham group,the rats in the other groups were subjected to middle cerebral artery occlusion(MCAO)ischemia for 2 h,and then the embolus removal for reperfusion.And 24 h later,the rats went on corresponding 14 d course intervention of 27.68 g/kg/d,13.84 g/kg/d,6.92 g/kg/d of supplemented Yiqi Tongxuan Formula,and 60 mg/kg/d of aspirin.Modified neurological severity scores(mNSS),triphenyltetrazol chloride(TTC)staining,hematoxylin-eosin(HE)staining and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling(TUNEL)were used to assess the protective effect of supplemented Yiqi Tongxuan Formula on cerebral ischemia reperfusion injury rats.Western blot was used to detect the expression of PI3K/Akt-eNOS signaling pathway-related proteins and apoptosis-related proteins Bcl-2,Bax,and cleaved-Caspase3.RESULTS Supplemented Yiqi Tongxuan Formula significantly reduced the neurobehavioral score,the infarct rate,the pathological damage of brain tissue,and the apoptotic rate of brain tissue.It also increased the PI3K/Akt-eNOS signaling pathway-related p-Akt and p-eNOS protein expression,increased the expression of anti-apoptotic protein Bcl-2,decreased the expression of pro-apoptotic proteins Bax,cleaved-Caspase3 and the ratio of Bax/Bcl-2.CONCLUSION Supplemented Yiqi Tongxuan Formula can improve cerebral ischemia reperfusion injury in rats,and its mechanism may be associated with the activation of PI3K/Akt-eNOS pathway.
Keywords:Supplemented Yiqi Tongxuan Formula  cerebral ischemia-reperfusion  PI3K/Akt-eNOS pathway  apoptosis
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号